Seminars in Spine Surgery
Volume 21, Issue 4 , Pages 216-222 , December 2009

Decision Analysis and Cost-Effectiveness Analysis

  • Hilary F. Ryder, MD

      Affiliations

    • Department of Medicine, Dartmouth Medical School, Lebanon, NH
    • Corresponding Author InformationAddress reprint requests to Hilary F. Ryder, MD, Department of Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756
    • ,
  • Christene M. McDonough, PT, PhD

      Affiliations

    • Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, NH
    • The Health and Disability Research Institute, Boston University, Boston, MA
    • ,
  • Anna N.A. Tosteson, ScD

      Affiliations

    • Departments of Medicine and of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH
    • ,
  • Jon D. Lurie, MD, MS

      Affiliations

    • Departments of Medicine and of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH

References 

  1. Sox H, Blatt M, Higgins M, et al. Medical Decision Making. (ed 2). Philadelphia, PA: American College of Physicians; 2007;
  2. Hunink M, Glasziou P, Siegel J, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge: Cambridge University Press; 2001;
  3. Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton, NJ: Princeton University Press; 1944;
  4. Torrance G, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states?. Med Decis Mak. 2001;21:329–334
  5. Parkin D, Devlin N. Is there a case for using visual analogue scale valuations in cost-utility analysis?. Health Econ. 2006;15:653–664
  6. Bleichrodt H. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 2002;11:447–456
  7. Torrance G, Furlong W, Feeny D. Health utility estimation. Expert Rev Pharmacoecon Outcomes Res. 2002;2:99–108
  8. van Osch S, Wakker P, van den Hout W, et al. Correcting biases in standard gamble and time tradeoff utilities. Med Decis Mak. 2004;24:511–517
  9. Peul W, van den Hout W, Brand R, et al. Prolonged conservative care versus early surgery in patients with sciatica caused by lumbar disc herniation: two year results of a randomised controlled trial. BMJ. 2008;336:1355–1358
  10. Weinstein J, Lurie J, Tosteson T. Surgical vs nonoperative treatment for lumbar disc herniation: the spine patient Outcomes Research Trial (SPORT) observational cohort. JAMA. 2006;296:2451–2459
  11. Weinstein J, Tosteson T, Lurie J. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA. 2006;296:2441–2450
  12. Gold M, Siegel J, Russell L, et al. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996;
  13. Dawson B, Trapp R. Basic and Clinical Biostatistics. (ed 4). New York: Lange Medical; 2004;
  14. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13:1203–1210
  15. Brooks R. EuroQol: the current state of play. Health. 1996;37:53–72
  16. Dolan P. Modelling valuations for EQ-5d health states (An alternative model using differences in valuations). Med Care. 2002;40:442–446
  17. Torrance G, Furlong W, Feeny D, et al. Multi-attribute preference functions (Health utilities index). Pharmacoeconomics. 1995;7:503–520
  18. Kaplan R, Anderson J. A general health policy model: update and applications. Health Serv Res. 1988;23:203–235
  19. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292
  20. Pauker S, Kassirer J. Decision analysis. N Engl J Med. 1987;316:250–258
  21. Weinstein M, Stason W. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716–721
  22. Drummond M, O'Brian B, Stoddart G, et al. Methods for the Economic Evaluation of Health Care Programmes. (ed 2). New York: Oxford University Press; 1997;
  23. Weinstein M, Siegel J, Gold M, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–1258
  24. Russell L, Gold M, Siegel J, et al. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276:1172–1177
  25. Evans C, Tavakoli M, Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluation: a critical appraisal. Health Care Manage Sci. 2004;7:43–49
  26. Kassirer J, Angell M. The Journal's policy on cost-effectiveness analyses. N Engl J Med. 1994;331:669–670
  27. Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J. 2007;16:329–337
  28. Tosteson A, Skinner J, Tosteson T, et al. The Cost Effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years. Spine. 2008;33:1–8
  29. Malter A, Larson E, Urban N, et al. Cost-effectiveness of lumbar discectomy for the treatment of herniated intervertebral disc. Spine. 1996;21:1048–1054
  30. Atlas S, Deyo R, Keller RB. The Maine lumbar spine study (Part II. 1-Year outcomes of surgical and nonsurgical management of sciatica). Spine. 1996;21:1777–1786
  31. van den Hout W, Peul W, Koes B, et al. Prolonged conservative care versus early surgery in patients with sciatica from lumbar disc herniation: cost utility analysis alongside a randomised controlled trial. BMJ. 2008;336:1351–1354
  32. Siegel J, Weinstein M, Russell L, et al. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276:1339–1341
  33. Chapman R, Berger M, Weinstein M, et al. When does quality-adjusting life-years matter in cost-effectiveness analysis?. Health Econ. 2004;13:429–436
  34. Donaldson C, Currie G, Mitton C. Cost effectiveness analysis in health care: contraindications. BMJ. 2002;325:891–894
  35. Neumann P, Greenberg D, Olchanski N, et al. Growth and quality of the cost-utility literature, 1976-2001. Value Health. 2005;8:3–9
  36. Bloom B. Use of formal benefit/cost evaluations in health care decision making. Am J Manag Care. 2004;10:329–335
  37. Siegel J. Cost-effectiveness analysis in US healthcare decision-making: where is it going?. Med Care. 2005;43(suppl 7):II1–II4
  38. Aspinall S, Good C, Glassman P, et al. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veteran Affairs. Med Care. 2005;43(suppl 7):II20–II26
  39. Guyatt G, Baumann M, Paulker S, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest. 2006;129:182–187
  40. Luce B. What will it take to make cost-effectiveness analysis acceptable in the United States?. Med Care. 2005;43(suppl 7):II44–II48
  41. Tunis S. Economic analysis in healthcare decisions. Am J Manag Care. 2004;10:301–304

 This work was supported in-part by a grant from the National Institute for Arthritis, Musculoskeletal and Skin Diseases (P60-AR048094-01A1).

PII: S1040-7383(09)00068-9

doi: 10.1053/j.semss.2009.08.003

Seminars in Spine Surgery
Volume 21, Issue 4 , Pages 216-222 , December 2009

Article Tools

* Image Usage & Resolution